Cary Street Partners Investment Advisory LLC Regeneron Pharmaceuticals, Inc. Transaction History
Cary Street Partners Investment Advisory LLC
- $152 Billion
- Q4 2024
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 366 shares of REGN stock, worth $258,948. This represents 0.17% of its overall portfolio holdings.
Number of Shares
366
Previous 4,074
91.02%
Holding current value
$258,948
Previous $4.28 Million
5988.56%
% of portfolio
0.17%
Previous 0.16%
Shares
12 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.57 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.98 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.99 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.42 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.35 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $75.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...